AMBERSAN medical technology Co., Ltd.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
Locally manufactured in Taiwan, the ECP (External Counterpulsation) device is a non-invasive auxiliary device for cardiovascular symptoms. AMBERSAN medical technology Co., Ltd. has established a comprehensive quality management system. By integrating artificial intelligence, the company leads medical equipment into the clinical application field of smart healthcare, positioning itself as a next-generation leader in the medical industry.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2019
Unified Business No.
85064362
Status
Active
Number of Employees
0
Total Paid-in
Capital
66,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AMBERSAN is one of Taiwan's top medical equipment manufacturers, focusing on the fields of cardiology, respiration, and long-term care. Currently, AMBERSAN's main product is the enhanced ECP device, abbreviated as EECP (Enhanced External Counter Pulsation) external counterpulsation device, and it is the only manufacturer in Taiwan capable of collaboratively designing, developing, and producing enhanced ECP. In the coming years, AMBERSAN aims to combine medical experience with the silicon industry's outstanding research and development capabilities, leading Taiwan's health industry toward an era of a disease-free world.
(The content above was translated by AI.)
(The content above was translated by AI.)
